13 Posts Not To Miss From CICON24

The Eighth International Cancer Immunotherapy Conference (CICON24) took place from September 8 to 11, 2024, at the Gaylord National Resort and Convention Center in National Harbor, MD.

Organized by the Cancer Research Institute (CRI) and the European Network for Cancer Immunotherapy (ENCI), the conference’s theme was “Translating Science into Survival.”

The program featured presentations from over 60 experts in cancer immunology and immunotherapy, addressing various topics within the field. Attendees engaged in discussions about the latest advancements, including neoadjuvant and platform trials, multiomic data analysis, and personalized therapies, among others.

Here are some highlights from CICON24:

Cancer Research Institute:

“The Eighth International Cancer Immunotherapy Conference officially kicked off today, sparking groundbreaking discussions and showcasing pioneering research!

Discover the cutting-edge ideas and illuminating presentations shared during the first day of CICON24, from scientists including CRI Scientific Advisory Council Associate Director Dr. Elizabeth Jaffee of Johns Hopkins Medicine, Dr. Max Krummel of University of California, San Francisco, and CRI-Dr. Keith Landesman Memorial Fellow Dr. Kevin Ng of The Rockefeller University, in the Cancer Research Institute’s daily recap blog. Explore.”

Tullia Bruno:

“Part of the fun of CICON24 is spending time with old and new friends! I feel honored to stand next to these two rockstars Jennifer Guerriero and Saman Maleki … just goes to show that B cells, myeloid cells, and the microbiota can be friends.”

Cancer Research Institute:

“During CICON24’s first session, Memorial Sloan Kettering Cancer Center’s Dr. Luis Diaz Jr. dove into the groundbreaking potential of immunoablative neoadjuvant therapy, an approach that uses the power of the immune system to target and shrink tumors before surgery, offering new hope to patients.”

Giulia Furesi:

“Great first experience at CICON24! Amazing science, inspiring talks, and fantastic people. Thank you to CRI-ENCI for hosting such an incredible event!”

Cancer Research Institute:

“CRI Lloyd J. Old STAR Dr. Ping-Chih Ho of University of Lausanne, describes how the environment at CICON24 naturally lends itself to collaboration and creative problem solving.”

George Alzeeb:

“Thrilled to share that I had the opportunity to present Brenus Pharma ‘s latest poster at the 8th International Cancer Immunotherapy Conference (CICON24) in National Harbor!

Our poster showcased groundbreaking data from the STC-1010 candidate vaccine for treating colorectal cancer, highlighting fascinating results from our multi-omics characterization. This comprehensive approach has provided us with deeper insights into the vaccine’s manufacturing potential.

A huge thank you to all my collaborators and colleagues whose hard work and dedication made this possible Corentin Richard, Romain Boidot, ANAQUANT.

The conference is still ongoing until September 11th, and I am eagerly looking forward to more insightful sessions and networking opportunities with fellow researchers and professionals in the field. Let’s continue to push the boundaries of science and make strides towards a cancer-free future!”

Cancer Research Institute:

“Dr. Vinod Balachandran of Memorial Sloan Kettering Cancer Center presents on RNA vaccines for pancreatic cancer, during CICON24’s final session.”

Saman Maleki:

“Had a great time attending CICON24 and learning from top researchers in the field about the progress in cancer immunotherapy, presenting our work in oncomicrobiome and IO, and catching up with friends.”

Cancer Research Institute:

“2008 CRI Investigator Award recipient Dr. Hongbo Chi of St. Jude Research presents during CICON24’s seventh session, ‘Metabolic Pathways in the Clinic.’ ”

Laura Cogrossi:

“Excited to share results from Nutrivention trial and mouse study to prevent progression from SMM to myeloma at CICON24 in Washington DC. Great environment and shared interest in cancer immunotherapy. Acknowledgments to ⁦Urvi Shah⁩ leading the clinical study.”

Cancer Research Institute:

“Dr. Magnus Essand from Uppsala University presents groundbreaking advancements in using CAR T cells equipped with the bacterial virulence factor NAP to target glioblastoma and enhance immune response, during the ninth session of CICON24.”

Flavia Fico:

“Just wrapped up this amazing conference at Gaylord National Resort and Convention Center. A bit thanks to the organizers, speakers and other attendees!”

Jenna Newman:

“Thank you CRI for hosting an amazing conference CICON24 and providing special opportunities for CRI postdoctoral fellows to bond! CICON is the perfect sized meeting and covered so much breadth; really grateful to have attended these past 3 years! Cheers to ‘25!”

More posts featuring CICON24 on oncodaily.com